| P50 | author | Vin Tangpricha | Q37828961 |
| P2093 | author name string | Jessica Alvarez | |
| | Malcolm Kearns | |
| P2860 | cites work | High Prevalence of Vitamin D Inadequacy and Implications for Health | Q22305468 |
| | Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | Q22306207 |
| | The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know | Q22306208 |
| | Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study | Q28288828 |
| | IOM committee members respond to Endocrine Society vitamin D guideline | Q33569932 |
| | Vitamin D and bone health in adults with cystic fibrosis | Q33775720 |
| | Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study | Q33891780 |
| | Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications | Q33953964 |
| | Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial | Q34180229 |
| | Vitamin D deficiency and risk of cardiovascular disease | Q34586829 |
| | Plasma 25-hydroxyvitamin D levels and risk of incident hypertension | Q34610247 |
| | A single dose of vitamin D enhances immunity to mycobacteria | Q34623455 |
| | Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study | Q35559525 |
| | Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial | Q36187630 |
| | Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update | Q36480593 |
| | Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. | Q36802466 |
| | 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study | Q37035497 |
| | Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial | Q38373595 |
| | The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial | Q39798134 |
| | High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro | Q42501627 |
| | The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial | Q42993191 |
| | The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome | Q43263695 |
| | Adherence to calcium/vitamin D and estrogen protocols among diverse older participants enrolled in a clinical trial | Q43649546 |
| | Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women: a community primary prevention study | Q43688465 |
| | Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients | Q45139322 |
| | Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly. | Q45813771 |
| | High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. | Q45962199 |
| | Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population? | Q46160829 |
| | High-dose oral vitamin D3 supplementation in the elderly. | Q46186830 |
| | The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency | Q46259166 |
| | The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. | Q46268516 |
| | Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality | Q46523052 |
| | Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. | Q46585248 |
| | Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey | Q47674779 |
| | The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study | Q48674452 |
| | Annual high-dose vitamin D3 and mental well-being: randomised controlled trial | Q48881261 |
| | Annual injection of vitamin D and fractures of aged bones. | Q50541730 |
| | Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. | Q50582992 |
| | Annual high-dose vitamin D prophylaxis in Asian immigrants | Q50583928 |
| | Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. | Q51453737 |
| | Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh | Q57936109 |
| | Short-Term Effects on Bone Turnover Markers of a Single High Dose of Oral Vitamin D3 | Q58903540 |
| | A Randomized, Controlled Trial of Quadriceps Resistance Exercise and Vitamin D in Frail Older People: The Frailty Interventions Trial in Elderly Subjects (FITNESS) | Q60529871 |
| | Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis | Q60711031 |
| | The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D2) or cholecalciferol (D3) in alcoholic liver cirrhosis | Q63728597 |
| | Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men | Q71247585 |
| | Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults | Q71582911 |
| | Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial | Q72395213 |
| | Vitamin D | Q72395503 |
| | Pharmacokinetics of a single, large dose of cholecalciferol | Q80836604 |
| | An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men | Q81153046 |
| | Vitamin D deficiency and supplementation during pregnancy | Q81930448 |
| | Serum 25-hydroxy vitamin D and exercise capacity in COPD | Q82243102 |
| | Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients | Q83074657 |
| | Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study | Q83527054 |
| | Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study | Q84620279 |
| | Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene | Q85056214 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| | vitamin D | Q175621 |
| | systematic review | Q1504425 |
| P304 | page(s) | 341-51 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Endocrine Practice | Q15761577 |
| P1476 | title | Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review | |
| P478 | volume | 20 | |